Alexion Pharmaceuticals Inc $158.99

down -4.69


31/7/2014 04:00 PM  |  NASDAQ : ALXN  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get ALXN Trend Analysis - it has outperformed the S&P 500 by 22%

Partner Headlines

  1. Many Leading Stocks Damaged As Market Tumbles Broadly

    IBD
  2. Stocks Feint Higher, Then Slip; Pending Home Sales Down In June

    IBD
  3. Biotechs Fall Despite Beats

    IBD
  4. Celgene, Alexion Beat Estimates, But Biotechs Fall

    IBD
  5. Celgene, Alexion Earnings Top Street, But Stocks Fall

    IBD
  6. Stocks Up And Down At Open; Under Armour, Facebook Surge

    IBD
  7. US Stock Futures Gain Ahead Of Earnings, Economic Data

    Benzinga
  8. Biogen, Gilead Crush Earnings Estimates On Hot Drugs

    IBD
  9. S&P 500 Posts New High; Biotechs, Airlines, Builders Up

    IBD
  10. S&P 500 Aims At New High; Biotechs Gap Up In Fast Trade

    IBD
  11. Biogen Trounces Q2 Estimates As Tecfidera Outperforms

    IBD
  12. Alexion, 3 Other Top Biotechs Reporting Earnings

    IBD
  13. Stocks Climb In Solid Trade; Chipotle Gaps Up, Breaks Out

    IBD
  14. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  15. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  16. IBD 50 Ends Week Lower But Skyworks Soars

    IBD
  17. Will New Drug Give Alexion Pharmaceuticals A Boost?

    IBD
  18. Biogen's Profit Rolls Amid Recent Drug Launches

    IBD
  19. Inside The IBD 50: Leaders Show Mixed Action

    IBD
  20. Alexion Pharma Looks To Life Beyond Its Blockbuster

    IBD
  21. Raptor Announces CEO Succession Plan; Dr. Christopher Starr To Retire As ...

    Benzinga
  22. Citi Sees Plenty Of Q2 Earnings Beats Ahead In Biotech Sector

    Benzinga
  23. 4 Biotech Stocks Worth A Look Ahead Of FDA Approvals

    Benzinga
  24. Stocks Mixed As Losses Pared; Foot Locker Steps Up

    IBD
  25. Growth Stocks Kick Into Gear In Latest IBD 50 Screen

    IBD
  26. Techs, Small Cap Stocks Lead; Family Dollar Heads Group Rally

    IBD
  27. After The Biotech Sell-off, How Will Investors Treat Alexion Pharmaceuticals?

    IBD
  28. Alexion, Priceline, OpenTable: A Top Manager's View

    IBD
  29. Market Wrap For May 5: Dow Erases Triple-Digit Loss, All Three Major Indices ...

    Benzinga
  30. US Stock Futures Decline After China Data

    Benzinga
  31. Earnings Growth Anemic But Medical Sector Healthy

    IBD
  32. Kors Among 5 Stocks With Superior 3-Year EPS Growth

    IBD
  33. Amgen Blazed Biotech Trail, Earned 165,233% Reward

    IBD
  34. Alexion Tops, Celgene Mixed

    IBD
  35. Stocks Mixed In Late Trade; Goodyear Breaks Out

    IBD
  36. Nasdaq Leads As Indexes Reverse Upward

    IBD
  37. Alexion, Celgene Report Contrasting Q1 Earnings

    IBD
  38. US Stock Futures Surge After Upbeat Apple Earnings

    Benzinga
  39. US Stock Futures Edge Lower Ahead Of Earnings

    Benzinga
  40. A Drill Can Help Identify Right Time To Sell Leaders

    IBD
  41. Biohazard? Gilead Leads 5 Big-Cap Biotech Earnings

    IBD
  42. Facebook, Walgreen Climb Monday On International News

    IBD
  43. IPO Frenzy Freezes As 4 New Issues Delayed

    IBD
  44. Stocks Fall In Higher Volume; Alexion, Gilead Drop 7%

    IBD
  45. Nasdaq Up 1.7%; Bed, Bath & Beyond Sinks After Hours

    IBD
  46. Stocks Extend Gains; Trimble Navigation Finds Support

    IBD
  47. Alexion, Biogen Among Leading Big-Cap Biotechs

    IBD
  48. Nasdaq Sheds 1% As China Growth Names, Biotechs Fall Hard

    IBD
  49. S&P 500 Edges Lower As Biotech Selling Weighs On Nasdaq

    IBD
  50. Nasdaq Leads Another Up Day; S&P 500 Hits All-Time High

    IBD
Trading Center